Back to all startups
Hims & Hers
Telehealth · Telehealth Rx + OTC (global)
Public (HIMS)Global
HQSan Francisco, CA, USA
Founded2017
FoundersAndrew Dudum
RegionGlobal
Financials
FY24 Revenue$1.48B (2024, +69%); $2.35B (2025, +59% YoY)
FY25 Revenue$2.35B (2025, +59% YoY)
YoY growth+59-69% YoY
Profitabilityprofitable, adj EBITDA strongly positive
Channels & Distribution
D2C · 100%
D2C100%
Marketplace—
Offline—
Stores—
Tech stack
Primary stackCustom
Shopify share0%In-house: 100%
Mobile appYes
Stack signals
Custom proprietary platform (Rx-licensed pharmacy + telehealth)
CRM: Custom
Analyst notes
SF telehealth Rx + OTC founded 2017 by Andrew Dudum. Public HIMS via SPAC Jan 2021 @ $1.6B. $1.48B 2024 (+69%); $2.35B 2025 (+59% YoY). Mkt cap ~$6.37B Jun 2026. Custom proprietary platform. DTC subscription only.
Confidence: verifiedVerified 5 Jun 2026
Funding
Latest roundIPO via SPACJan 2021
Round size@ $1.6B (Jan 2021)
Total raised—
ValuationMkt cap ~$6.37B (Jun 2026); $7.40B (Dec 2025)Jun 2026
Investors
Public